Tobramycin Sulfate is a potent aminoglycoside antibiotic widely utilized in compounded formulations for its efficacy against a broad spectrum of gram-negative bacterial infections.
Tobramycin Sulfate is a potent aminoglycoside antibiotic widely utilized in compounded formulations for its efficacy against a broad spectrum of gram-negative bacterial infections. It functions by binding to the 30S ribosomal subunit, thereby inhibiting protein synthesis and leading to bacterial cell death. This mechanism of action makes Tobramycin Sulfate particularly effective in treating severe infections caused by susceptible strains of bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella species.
In clinical settings, Tobramycin Sulfate is often prescribed for patients with complicated respiratory tract infections, urinary tract infections, and skin infections, among others. Its use in compounded formulations allows for tailored dosing and delivery methods, enhancing patient compliance and therapeutic outcomes. The pharmacokinetics of Tobramycin Sulfate, characterized by rapid absorption and distribution, make it a preferred choice for acute and chronic infection management.
Prescribers should be aware of the potential nephrotoxic and ototoxic effects associated with Tobramycin Sulfate, particularly in patients with pre-existing renal impairment or those receiving prolonged therapy. Monitoring of serum drug levels and renal function is recommended to mitigate these risks. Additionally, the antibiotic's synergistic effects with other antimicrobial agents can be leveraged in combination therapies to enhance antibacterial efficacy.
Bayview Pharmacy's expertise in compounding allows for the customization of Tobramycin Sulfate formulations to meet specific patient needs, ensuring optimal therapeutic results. By understanding the unique properties and clinical applications of Tobramycin Sulfate, healthcare providers can make informed decisions in the management of complex bacterial infections. This API's versatility and effectiveness underscore its importance in modern pharmaceutical compounding practices.
Each of these is compounded to order at our Warwick, Rhode Island pharmacy and requires a prescription.
A sample of preparations from our formulary. Strengths and dose forms are customised to the prescription.
"Fortified" means the eye drop is compounded at a much higher concentration than the standard commercial tobramycin drop, which is 0.3% (3 mg/mL). Bayview compounds it at 15 mg/mL and 13.6 mg/mL, roughly five times the commercial strength, because a serious eye infection can need more antibiotic delivered to the surface of the eye.
It is used to treat serious bacterial eye infections, most often bacterial keratitis (a corneal infection or ulcer), especially when gram-negative bacteria such as Pseudomonas are involved or suspected. An eye specialist prescribes and monitors it, often based on cultures of the infection.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.